January 21, 2021 Future Market Insights Releases
Future Market Insights, Dubai: The market for prothrombin complex concentrates is expected to grow steadily with a CAGR of 4.5% until the end of 2028. The coronavirus pandemic should offer short-term lucrative opportunities for participants in the prothrombin complex concentrates market. The need for blood coagulants in health care during the crisis is likely to hurt market participants. However, the market should continue to grow after the pandemic as the incidence of chronic diseases continues to rise.
“A key factor influencing market development is the growing investments by market participants in expanding the supply and distribution networks of plasma centers. This is expected to lead to efforts to innovate in production processes in the industry, ”the FMI study says.
The coronavirus pandemic has had a positive impact on the market for prothrombin complex concentrates. The increased spending on the mass supply of essential medicines in the health sector has supported short-term demand.
The higher production rates and deliveries of Factor IX during the Covid-19 pandemic are also driving business activity in the industry. The increased demand for plasma and blood during the pandemic will fuel the growth of the industry. This trend is unlikely to change after a pandemic and it is widely used for other chronic disease treatments.
Some of the leading manufacturers entering the Prothrombin Complex Concentrate market are Shire, Grifols SA, Octapharma AG, Kedrion Biopharma Inc., Nihon Pharmaceutical Co. Ltd., CSL Behring GmbH and Sanquin Blood Supply Foundation.
Leading players in the Prothrombin Complex Concentrate market have shown increased interest in expanding research on Prothrombin Complex Concentrates to determine the impact on applications in the Understand healthcare better.
For example, Novo Nordisk’s NovoSeven was linked to lower levels of dangerous blood clots in a review study in September 2019. Portola Pharmaceuticals has published new in vitro research data on the use of 4-factor PCC that does not indicate a direct association with the inhibition of thrombin generation. Chugai Pharmaceuticals and Genentech have published preliminary real-world results of Hemlibra showing the drug’s effectiveness in adults and children with hemophilia.
Explore Prothrombin Complex Concentrate Market data with 166 Figures, 36 Tables, and ToC. You can also find market segmentation at https://www.futuremarketinsights.com/toc/rep-gb-7021
FMIs provide detailed insights into the Prothrombin Complex Concentrate market. The market is divided by product type (3-factor PCC and 4-factor PCC), indication (hemiophilia B, trauma, life-threatening coagulopathy with acute bleeding, warfarin-associated acute, life-threatening bleeding and non-warfarin anticoagulant) reversal with acute Bleeding) and distribution channel (retail pharmacies, hospital pharmacies, and compound pharmacies) in seven regions (North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China & Japan, Japan, China, and Middle East & Africa).
Dialysis Machine Market: Find insights into the Dialysis Equipment Market with an analysis of statistics, segments, players, drivers, and business strategies adopted over a forecast period of 10 years.
Poultry Diagnostics Market: The FMI’s report on the Poultry Diagnostics Market provides Insights into the market for 2020-2030. The study evaluates restraint forces, revenue streams, market leaders and market strategies.
Digital Wound Gauges Market: An analysis of the digital wound gauges market with data on opportunities, growth levers, regional markets, restrictions, regulatory guidelines, and strengths of market leaders.
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving customers in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the US and India. The latest market research reports and industry analyzes from FMI help companies master challenges and make critical decisions in the breakneck competition with confidence and clarity. Our bespoke and syndicated market research reports provide actionable insights that drive sustainable growth. A team of experts at FMI continually tracks emerging trends and events in a variety of industries to ensure our customers prepare for the changing needs of their consumers.
Medical technology is changing the world! Join in and see the progress in real time. At Medgadget, we have been reporting on the latest technology news, interviewing local leading companies, and archiving mailings of medical events around the world since 2004.
Ref: https://www.medgadget.com
